pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Opzelura · news · pharmadog
← back to Opzelura
News mentioning Opzelura
10
stories
22d
Incyte cuts early-stage cancer drug to focus on next-gen programs
biospace
23d
Incyte ditches phase 1-stage JAK inhibitor to pursue next-gen options
fiercebiotech
Jul 16, 26
Racing Takeda, InnoCare reports TYK2 inhibitor win in phase 2 vitiligo trial
fiercebiotech
Jun 26, 26
On second try, Acadia drug gets nod from European regulators
biopharma dive
Jun 15, 26
Lilly scores early positive data for new JAK drug
biopharma dive
Jun 8, 26
Incyte CEO sees $2B Vega deal aiding a post-Jakafi future
endpoints
Jun 8, 26
Incyte to buy blood disorder drug in possibly $2B deal
biopharma dive
May 10, 26
Five Under 5: Top Oncology Videos for the Week of 5/3
onclive
May 5, 26
Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosis
onclive
Apr 27, 26
Lilly to buy startup Ajax in bid for a better JAK drug
biopharma dive
